Cristin-person-ID: 389572
Person

Augun Jodis Blindheim

  • Stilling:
    Universitetslektor
    ved Institutt for klinisk og molekylær medisin ved Norges teknisk-naturvitenskapelige universitet
  • Stilling:
    Overlege
    ved Kirurgisk klinikk ved St. Olavs Hospital HF

Resultater Resultater

Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway.

Møller, Christina Tanem; Tafjord, Gunnar; Blindheim, Augun Jodis; Berge, Viktor; Fosså, Sophie Dorothea; Kulle, Bettina. 2023, Scandinavian Journal of Urology. STOLAV, NTNU, UIO, OUS, KREFTREGVitenskapelig artikkel

Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study.

Møller, Christina Tanem; Støer, Nathalie Charlotte; Blindheim, Augun; Berge, Viktor; Tafjord, Gunnar; Fosså, Sophie Dorothea; Kulle, Bettina. 2022, BMC Cancer. STOLAV, NTNU, UIO, OUS, KREFTREGVitenskapelig artikkel

The use of reTURB in T1 bladder cancer: a Norwegian population-based study.

Blindheim, Augun; Fosså, Sophie Dorothea; Babigumira, Ronnie; Andreassen, Bettina Kulle. 2021, Scandinavian Journal of Urology. STOLAV, NTNU, UIO, OUS, KREFTREGVitenskapelig artikkel

T1 bladder cancer in Norway: treatment and survival.

Blindheim, Augun Jodis; Fosså, Sophie Dorothea; Babigumira, Ronnie; Myklebust, Tor Åge; Haug, Erik Skaaheim; Arum, Carl-Jørgen; Kulle, Bettina. 2020, Scandinavian Journal of Urology. HELSEMR, STOLAV, VESTFOLD, NTNU, UIO, OUS, KREFTREGVitenskapelig artikkel

"Two hits - one stone" increased efficacy of cisplatin-based therapies by targeting PCNA's role in both DNA repair and cellular signaling.

Søgaard, Caroline Krogh; Blindheim, Augun; Røst, Lisa Marie; Petrovic, Voin; Nepal, Anala; Bachke, Siri; Liabakk, Nina-Beate; Gederaas, Odrun Arna; Viset, Trond; Arum, Carl-Jørgen mfl.. 2018, OncoTarget. STOLAV, NTNUVitenskapelig artikkel
1 - 5 av 6 | Neste | Siste »